(As of March 31, 2018)
MEDIPAL HOLDINGS CORPORATION
Head Office2-7-15, Yaesu, Chuo-ku,
Tokyo 104-8461 Japan
TEL: 81-3-3517-5800 Access Map
October 8, 1898
May 6, 1923
Shuichi Watanabe, Representative Director, President and CEO
22,398 million yen
Tokyo Stock Exchange, First Section
Line of Business
As a holding company, MEDIPAL HOLDINGS controls, administers and supports the operating activities of companies in which it holds shares in the Prescription Pharmaceutical Wholesale Business;the Cosmetics, Daily Necessities and OTC Pharmaceutical Wholesale Business; and the Animal Health Products and Food Processing Raw Materials Wholesale Business, and conducts business development for the MEDIPAL Group.
Takeda Pharmaceutical Company Limited, Japan Trustee Services Bank, Ltd. (Trust Account), MEDICEO Employees Shareholders' Association of MP Group, The Master Trust Bank of Japan, Ltd. (Trust Account), Japan Trustee Services Bank, Ltd.(Eisai Co., Ltd. Retirement Benefit Trust Account re-entrusted by Sumitomo Mitsui Trust Bank Ltd.), Kobayashi Pharmaceutical Co., Ltd., Northern Trust Co. (Avfc) Re The Kiltearn Global Equity Fund, Japan Trustee Services Bank, Ltd. (Trust Account 5), State Street Bank West Client - Treaty 505234, Trust & Custody Services Bank, Ltd. as trustee for Daiichi Sankyo Company, Limited Retirement Benefit Trust Account re-entrusted by Mizuho Trust and Banking Co., Ltd.
Notes : The Company holds 19,613 thousand shares of treasury stock, which are excluded from the major shareholders listed above.
Fiscal Year End
Mizuho Bank, Ltd., Resona Bank, Limited, MUFG Bank, Ltd., Sumitomo Mitsui Banking Corporation